The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Caspase activation precedes and leads to tangles
Open accessAbstract
Studies of post-mortem tissue have shown that the location of fibrillar tau deposits, called neurofibrillary tangles (NFT), matches closely with regions of massive neuronal death, severe cytological abnormalities, and markers of caspase activation and apoptosis, leading to the idea that tangles cause neurodegeneration in Alzheimer's disease and tau-related frontotemporal dementia. However, using in vivo multiphoton imaging to observe tangles and activation of executioner caspases in living tau transgenic mice (Tg4510 strain), we find the opposite: caspase activation occurs first, and precedes tangle formation by hours to days. New tangles form within a day. After a new tangle forms, the neuron remains alive and caspase activity seems to be suppressed. Similarly, introduction of wild-type 4-repeat tau (tau-4R) into wild-type animals triggered caspase activation, tau truncation and tau aggregation. Adeno-associated virus-mediated expression of a construct mimicking caspase-cleaved tau into wild-type mice led to the appearance of intracellular aggregates, tangle-related conformational- and phospho-epitopes, and the recruitment of full-length endogenous tau to the aggregates. On the basis of these data, we propose a new model in which caspase activation cleaves tau to initiate tangle formation, then truncated tau recruits normal tau to misfold and form tangles. Because tangle-bearing neurons are long-lived, we suggest that tangles are 'off pathway' to acute neuronal death. Soluble tau species, rather than fibrillar tau, may be the critical toxic moiety underlying neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent evidence suggests that executioner caspases 3 and 7 may contribute to tau, the protein responsible for forming NFTs, pathology by cleaving tau after Asp421 to yield a cytotoxic Δtau fragment (Rissman et al., 2004; Rohn et al., 2008; de Calignon et al., 2010).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“may contribute to cognitive decline”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the early cleavage of tau by these caspases initiates tau aggregation and phosphorylation”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
In the citing paper
“Mitochondrial abnormalities, synaptic loss and dysfunction, altered axonal transport, and activation of cell death pathways (including caspase activation and inflammatory responses) have all been directly or indirectly implicated as consequences of tau mislocalization or oligomerization (20, 40, 43–52).”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“For example, through direct visualization of the cortex of Tg4510 P301L mice by multiphoton microscopy, Hyman and colleagues were able to determine that caspase activation, and neuronal death, appeared in many instances to precede tangle formation.”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“Indeed, tangles forming did not lead to neuronal death over the course of the several-month imaging period (43, 51).”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“Recent data suggest that intracellular protein aggregates of tau have the capacity to seed aggregation of native tau proteins and might propagate their misfolded state in a prion-like manner.”
From Propagation of Tau Pathology in a Model of Early Alzheimer's Disease (2012) · cites this paper as de Calignon et al., 2010
In the citing paper
“The current clinical trial literature is compatible with the idea that AβP-related substances kindle a self-propagating process related to neocortical NFTs, as has been hypothesized (266-269).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [266]
In the citing paper
“whereas tau tangles alone are not sufficient to cause neuronal death”
From Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models (2019) · cites this paper as de Calignon et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Self-citationControl of memory formation through regulated expression of a CaMKII transgene
Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Self-citationAugustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998
Self-citationCaspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722
Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702
Self-citationTau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Wang, Y., Martinez-Vicente, M., Krüger, U., Kaushik, S., Wong, E., Mandelkow, E.-M., Cuervo, A. M., & Mandelkow, E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp367 · Cited by 617
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 525
Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia
Das, R. R., Balmik, A. A., & Chinnathambi, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1694-y · Cited by 130
Aluminum’s Involvement in the Progression of Alzheimer’s Disease
Walton, J. R. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121909 · Cited by 128
Caspase-6 and neurodegeneration
Graham, R. K., Ehrnhoefer, D. E., & Hayden, M. R. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.09.001 · Cited by 127
Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., & Gasparini, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0082-7 · Cited by 126
Calderón‐Garcidueñas, L., Franco-Lira, M., Mora-Tiscareño, A., Medina‐Cortina, H., Torres‐Jardón, R., & Kavanaugh, M. (2013) · BioMed Research International · doi:10.1155/2013/161687 · Cited by 131
Synaptic alterations in the rTg4510 mouse model of tauopathy
Kopeikina, K. J., Polydoro, M., Tai, H., Yaeger, E., Carlson, G. A., Pitstick, R., Hyman, B. T., & Spires‐Jones, T. L. (2012) · The Journal of Comparative Neurology · doi:10.1002/cne.23234 · Cited by 129
Self-citationA Mitocentric View of Alzheimer's Disease Suggests Multi-Faceted Treatments
Gibson, G. E., & Shi, Q. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100336 · Cited by 124
Walton, J. R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132204 · Cited by 126
Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets
Pooler, A. M., Polydoro, M., Wegmann, S., Nicholls, S. B., Spires‐Jones, T. L., & Hyman, B. T. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt214 · Cited by 130
Self-citationA New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51
O’Leary, J. C., Dharia, S. P., Blair, L. J., Brady, S., Johnson, A. G., Peters, M. M., Cheung‐Flynn, J., Cox, M. B., de Erausquin, G. A., Weeber, E. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024840 · Cited by 128
The dendritic hypothesis for Alzheimer's disease pathophysiology
Cochran, J. N., Hall, A. M., & Roberson, E. D. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.004 · Cited by 114
Young, M. L., & Franklin, J. L. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103409 · Cited by 120
Calderón‐Garcidueñas, A. L., & Duyckaerts, C. J. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00023-7 · Cited by 126
Hamano, T., Enomoto, S., Shirafuji, N., Ikawa, M., Yamamura, O., Yen, S.-H. C., & Nakamoto, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147475 · Cited by 122
Di, J., Cohen, L. S., Corbo, C. P., Phillips, G. R., Idrissi, A. E., & Alonso, A. D. C. (2016) · Scientific Reports · doi:10.1038/srep20833 · Cited by 120
Therapeutic strategies for the treatment of tauopathies: Hopes and challenges
Khanna, M. R., Kovalevich, J., Lee, V. M. ‐., Trojanowski, J. Q., & Brunden, K. R. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.006 · Cited by 116
Hyperphosphorylation-Induced Tau Oligomers
Iqbal, K., Gong, C., & Liu, F. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00112 · Cited by 120
Suzuki, H., Lee, K., & Matsuoka, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.197483 · Cited by 116
Spreading of tau pathology in A lzheimer's disease by cell‐to‐cell transmission
Mohamed, N., Herrou, T., Plouffe, V., Piperno, N., & Leclerc, N. M. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12229 · Cited by 116
Are Tangles as Toxic as They Look?
Spires-Jones, T. L., Kopeikina, K. J., Koffie, R. M., de Calignon, A., & Hyman, B. T. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9566-7 · Cited by 104
Self-citationNatural Products As A Rich Source Of Tau-Targeting Drugs For Alzheimer’s Disease
Calcul, L., Zhang, B., Jinwal, U. K., Dickey, C. A., & Baker, B. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.124 · Cited by 108
Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Parodi‐Rullán, R. M., Sone, J. Y., & Fossati, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190357 · Cited by 110
Degeneration and repair in central nervous system disease
Lo, E. H. (2010) · Nature Medicine · doi:10.1038/nm.2226 · Cited by 111
Li, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103
Ljungberg, M. C., Ali, Y. O., Zhu, J., Wu, C.-S., Oka, K., Zhai, R. G., & Lu, H.-C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr492 · Cited by 107
Fossati, S., Giannoni, P., Solesio, M. E., Cocklin, S. L., Cabrera, E., Ghiso, J. A., & Rostagno, A. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.11.006 · Cited by 107
Wang, H., Shang, Y., Wang, E., Xu, X., Zhang, Q., Qian, C., Yang, Z., Wu, S., & Zhang, T. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102280 · Cited by 107
To the edge of cell death and back
Gong, Y., Crawford, J. C., Heckmann, B. L., & Green, D. R. (2018) · FEBS Journal · doi:10.1111/febs.14714 · Cited by 110
Figueiredo‐Pereira, M. E., Rockwell, P., Schmidt‐Glenewinkel, T., & Serrano, P. A. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00104 · Cited by 105
Variations in filament conformation dictate seeding barrier between three- and four-repeat Tau
Dinkel, P. D., Siddiqua, A., Huynh, H., Shah, M., & Margittai, M. (2011) · Biochemistry · doi:10.1021/bi2004685 · Cited by 104
Zhao, Y., Tseng, I.-C., Heyser, C. J., Rockenstein, E., Mante, M., Adame, A., Zheng, Q., Huang, T., Wang, X., Arslan, P. E., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.08.020 · Cited by 98
Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
Zhang, H., Cao, Y., Ma, L., Wei, Y., & Li, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.707268 · Cited by 109
Pathological Changes of Tau Related to Alzheimer’s Disease
Chu, D., & Liu, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00457 · Cited by 106
Ochoa, C. D., ALEXEYEV, M. F., Pastukh, V. V., Balczon, R., & Stevens, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301440 · Cited by 101
Mukherjee, A., & Williams, D. W. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.64 · Cited by 98
Rao, M. V., McBrayer, M. K., Campbell, J., Kumar, A., Hashim, A. T., Sershen, H. W., Stavrides, P. H., Ohno, M., Hutton, M., & Nixon, R. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1132-14.2014 · Cited by 101
Mouse models of frontotemporal dementia
Roberson, E. D. (2012) · Annals of Neurology · doi:10.1002/ana.23722 · Cited by 103
Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
Gómez-Isla, T., & Frosch, M. P. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00642-9 · Cited by 96
The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
Wolfe, M. S. (2012) · Scientifica · doi:10.6064/2012/796024 · Cited by 105
The Dynamic Structure of Filamentous Tau
Bibow, S., Mukrasch, M. D., Chinnathambi, S., Biernat, J., Griesinger, C., Mandelkow�, E., & Zweckstetter, M. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201105493 · Cited by 99
Loss of fused in sarcoma (FUS) promotes pathological Tau splicing
Orozco, D., Tahirović, S., Rentzsch, K., Schwenk, B. M., Haass, C., & Edbauer, D. (2012) · EMBO Reports · doi:10.1038/embor.2012.90 · Cited by 93
The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy
Zhang, C., Xing, A., Tan, M., Tan, L., & Yu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9415-8 · Cited by 98
Frontal Cortex Neuropathology in Dementia Pugilistica
Saing, T., Dick, M. B., Nelson, P. T., Kim, R. C., Cribbs, D. H., & Head, E. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1957 · Cited by 92
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
Pritchard, S. M., Dolan, P. J., Vitkus, A., & Johnson, G. V. W. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01273.x · Cited by 89
Caspases in synaptic plasticity
Li, Z., & Sheng, M. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-15 · Cited by 92
Fox, L. M., William, C. M., Adamowicz, D. H., Pitstick, R., Carlson, G. A., Spires-Jones, T. L., & Hyman, B. T. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318220a658 · Cited by 88
Self-citationNeural stem cell therapy for neurovascular injury in Alzheimer's disease
Boese, A. C., Hamblin, M. H., & Lee, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113112 · Cited by 89
Zinc-mediated Allosteric Inhibition of Caspase-6
Velázquez-Delgado, E. M., & Hardy, J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397752 · Cited by 84
Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease
Pérez, M. J., Vergara-Pulgar, K., Jara, C., Cabezas-Opazo, F., & Quintanilla, R. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0385-x · Cited by 81
Maarouf, C. L., Daugs, I. D., Kokjohn, T. A., Walker, D. G., Hunter, J. M., Kruchowsky, J., Woltjer, R. L., Kaye, J. A., Castaño, E. M., Sabbagh, M. N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027291 · Cited by 81
Wang, L., Du, Y., Wang, K., Xu, G., Luo, S., & He, G. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.006 · Cited by 81
δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities
Zhang, Z., Tian, Y., & Ye, K. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-019-0179-3 · Cited by 81
The influence of synaptic activity on neuronal health
Bell, K. F., & Hardingham, G. E. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.01.002 · Cited by 77
Wu, X., Piña-Crespo, J., Zhang, Y., Chen, X., & Xu, H. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.220313 · Cited by 82
Rho-kinase ROCK inhibitors reduce oligomeric tau protein
Hamano, T., Shirafuji, N., Yen, S.-H., Yoshida, H., Kanaan, N. M., Hayashi, K., Ikawa, M., Yamamura, O., Fujita, Y., Kuriyama, M., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.009 · Cited by 76
Korecka, M., & Shaw, L. M. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15465 · Cited by 82
Cdc37/Hsp90 Protein Complex Disruption Triggers an Autophagic Clearance Cascade for TDP-43 Protein
Jinwal, U. K., Abisambra, J. F., Zhang, J., Dharia, S. P., O’Leary, J. C., Patel, T., Braswell, K., Jani, T., Gestwicki, J. E., & Dickey, C. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367268 · Cited by 77
Park, S. A. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.1.10 · Cited by 74
Al‐kuraishy, H. M., Jabir, M. S., Albuhadily, A. K., Al-Gareeb, A. I., & Rafeeq, M. F. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102084 · Cited by 75
Kumar, S., Alibhai, D., Margineanu, A., Laine, R. F., Kennedy, G. T., McGinty, J., Warren, S. C., Kelly, D. J., Alexandrov, Y., Munro, I., et al. (2011) · ChemPhysChem · doi:10.1002/cphc.201000874 · Cited by 73
Contribution of proteases to the hallmarks of aging and to age-related neurodegeneration
Rai, M., Curley, M., Coleman, Z., & Demontis, F. (2022) · Aging Cell · doi:10.1111/acel.13603 · Cited by 72
The Use of Pigs as a Translational Model for Studying Neurodegenerative Diseases
Hoffe, B., & Holahan, M. R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00838 · Cited by 75
Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons
Quintanilla, R. A., Rommy von Bernhardi, M., Godoy, J. A., Inestrosa, N. C., & Johnson, G. V. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.016 · Cited by 70
Potential Long-Term Consequences of Concussive and Subconcussive Injury
Huber, B. R., Alosco, M. L., Stein, T. D., & McKee, A. C. (2016) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2015.12.007 · Cited by 78
Kim, Y., Choi, H., Lee, W., Park, H., Kam, T.-I., Hong, S.-H., Nah, J., Jung, S., Shin, B., Lee, H., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.006 · Cited by 71
Kim, B., Backus, C., Oh, S., & Feldman, E. L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121669 · Cited by 74
Ramser, E. M., Gan, K. J., Decker, H., Fan, E. Y., Suzuki, M. M., Ferreira, S. T., & Silverman, M. A. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-12-0858 · Cited by 74
Román, E. G. D. S., Manuel, I., Giralt, M. T., Ferrer, I., & Rodríguez‐Puertas, R. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.05.009 · Cited by 71
Protein phosphatase 2A and tau: an orchestrated ‘Pas de Deux’
Taleski, G., & Sontag, E. (2017) · FEBS Letters · doi:10.1002/1873-3468.12907 · Cited by 71
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
Balusu, S., & Strooper, B. D. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02747-5 · Cited by 76
Extensive p‐Tau Pathology and SDS‐Stable p‐Tau Oligomers in Alzheimer's Cortical Synapses
Henkins, K. M., Sokolow, S., Miller, C. A., Vinters, H. V., Poon, W. W., Cornwell, L. B., Saing, T., & Gylys, K. H. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00598.x · Cited by 69
Walton, J. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100486 · Cited by 70
Kulbe, J. R., & Hall, E. D. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.003 · Cited by 70
Lee, S., Lemere, C. A., Frost, J. L., & Shea, T. B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111025 · Cited by 68
Depletion of GGA1 and GGA3 Mediates Postinjury Elevation of BACE1
Walker, K. R., Kang, E. L., Whalen, M. J., Shen, Y., & Tesco, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-11.2012 · Cited by 66
Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
Canepa, E., & Fossati, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573324 · Cited by 67
Zafeiris, D., Rutella, S., & Ball, G. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.02.001 · Cited by 66
In vivoimaging reveals reduced activity of neuronal circuits in a mouse tauopathy model
Marinković, P., Blumenstock, S., Goltstein, P. M., Korzhova, V., Peters, F., Knebl, A., & Herms, J. W. (2019) · Brain · doi:10.1093/brain/awz035 · Cited by 63
Sun, G., Ding, X., Argaw, Y. G., Guo, X., & Montell, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-19068-2 · Cited by 64
Interaction between -Synuclein and Other Proteins in Neurodegenerative Disorders
Jellinger, K. A. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/371893 · Cited by 64
Fichou, Y., Al‐Hilaly, Y. K., Devred, F., Smet‐Nocca, C., Tsvetkov, P. O., Verelst, J., Winderickx, J., Geukens, N., Vanmechelen, E., Perrotin, A., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0682-x · Cited by 67
Miyata, Y., Koren, J., Kiray, J., Dickey, C. A., & Gestwicki, J. E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.88 · Cited by 64
Unni, V. K., Weissman, T. A., Rockenstein, E. M., Masliah, E., McLean, P. J., & Hyman, B. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010589 · Cited by 61
Self-citationCavallucci, V., Berretta, N., Nobili, A., Nisticò, R., Mercuri, N. B., & D’Amelio, M. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8241-2 · Cited by 61
Long, Z., Zhao, L., Jiang, R., Wang, K., Luo, S., Zheng, M., Li, X., & He, G. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12445 · Cited by 64
Formation, release, and internalization of stable tau oligomers in cells
Wegmann, S., Nicholls, S. B., Takeda, S., Fan, Z., & Hyman, B. T. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13866 · Cited by 66
Self-citationTangles, Toxicity, and Tau Secretion in AD – New Approaches to a Vexing Problem
Gendreau, K. L., & Hall, G. F. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00160 · Cited by 67
Nübling, G., Levin, J., Bader, B., Israel, L., Bötzel, K., Lorenzl, S., & Giese, A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.07.018 · Cited by 59
Pluta, R. M., Bogucka‐Kocka, A., Ułamek-Kozioł, M., Bogucki, J., Januszewski, S., Kocki, J., & Czuczwar, S. J. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.03.004 · Cited by 61
The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
Xu, Y., Uronen, R., & Huttunen, H. J. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.005 · Cited by 64
Singh, A., Allen, D., Fracassi, A., Tumurbaatar, B., Natarajan, C., Scaduto, P., Woltjer, R., Kayed, R., Limon, A., Krishnan, B., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200716 · Cited by 56
Cilento, E. M., Jin, L., Stewart, T., Shi, M., Sheng, L., & Zhang, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14635 · Cited by 60
Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization
Shirafuji, N., Hamano, T., Yen, S.-H. C., Kanaan, N. M., Yoshida, H., Hayashi, K., Ikawa, M., Yamamura, O., Kuriyama, M., & Nakamoto, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030891 · Cited by 59
Defective mitophagy and the etiopathogenesis of Alzheimer’s disease
Zeng, K., Yu, X., Mahaman, Y. A. R., Wang, J., Liu, R., Li, Y., & Wang, X. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00305-1 · Cited by 62
p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice
Walls, K. C., Ager, R. R., Vasilevko, V., Cheng, D., Medeiros, R., & LaFerla, F. M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.05.047 · Cited by 62
The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
Quntanilla, R. A., & Tapia-Monsalves, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200525020259 · Cited by 59
The Implications of Autophagy in Alzheimer’s Disease
Hamano, T., Hayashi, K., Shirafuji, N., & Nakamoto, Y. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666181004143432 · Cited by 57
Cell survival following direct executioner-caspase activation
Nano, M., Mondo, J. A., Harwood, J., Balasanyan, V., & Montell, D. J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216531120 · Cited by 58
Ułamek-Kozioł, M., Kocki, J., Bogucka‐Kocka, A., Petniak, A., Gil-Kulik, P., Januszewski, S., Bogucki, J., Jabłoński, M., Furmaga-Jabłońska, W., Brzozowska, J., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160387 · Cited by 57
Ramachandran, G., & Udgaonkar, J. B. (2013) · Biochemistry · doi:10.1021/bi400209z · Cited by 59
Metadata
- Authors
- de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- McLaughlin Research Institute (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2010-03-31
- Volume
- 464
- Issue
- 7292
- Pages
- 1201-1204
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3091360
- OpenAlex
- W2100026237
- Cited by
- 517
- References
- 31
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 12 · 2023: 30 · 2022: 24 · 2021: 28 · 2020: 26 · 2019: 19 · 2018: 26 · 2017: 38 · 2016: 40 · 2015: 39 · 2014: 26 · 2013: 48 · 2012: 54
- FWCI
- 39.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- National Institute on Aging (AG-08487, R01AG026249, R01AG008487, AG026249, P50AG005134, K99AG033670, P30AG062421)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- caspase activation, neurofibrillary tangles, tau protein, Alzheimer's disease, frontotemporal dementia, tau transgenic mice, neuronal survival, neurodegeneration, tau truncation, APOE ε4, APOE3, APOE2, APOE genotype, multiphoton imaging, tau aggregation
- MeSH terms
- Animals, Brain, Enzyme Activation, Humans, Mice, Transgenic, Neurons, Protein Processing, Post-Translational, Solubility, Time Factors, Neurofibrillary Tangles, tau Proteins, Cell Death, Caspases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
